Evidence map›Paper›PMID 35836200›Full record

ArticleJournal of neuroinflammation2022

NOX2-mediated reactive oxygen species are double-edged swords in focal cerebral ischemia in mice.

Ye Yingze, Jian Zhihong, Jin Tong, Li Yina, Zeng Zhi, Zhang Xu, Xiong Xiaoxing, Gu Lijuan

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 67 citations in OpenAlex.

  1. MnOMaterials today. Bio · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. The Roles of ProteinCancer communications (London, England) · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. NOX2 Contributes to High-Frequency Outer Hair Cell Vulnerability in the Cochlea.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ye Yingze *Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Jian Zhihong *Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Jin TongDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Li YinaCentral Laboratory, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Zeng ZhiDepartment of Pathology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Zhang XuCentral Laboratory, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Xiong XiaoxingCentral Laboratory, Renmin Hospital of Wuhan University, Wuhan, 430060, China. xiaoxingxiong@whu.edu.cn.
Gu LijuanCentral Laboratory, Renmin Hospital of Wuhan University, Wuhan, 430060, China. gulijuan@whu.edu.cn.
Wuhan University · CNRenmin Hospital of Wuhan University · CN

Funding

National Natural Science Foundation of China 81771283, 82071339National Natural Science Foundation of China 82171336, 81870939
6 · The paper itself

Abstract

backgroundReactive oxygen species (ROS) often promote acute brain injury after stroke, but their roles in the recovery phase have not been well studied. We tested the hypothesis that ROS activity mediated by NADPH oxidase 2 (NOX2) contributes to acute brain injury but promotes functional recovery during the delayed phase, which is linked with neuroinflammation, autophagy, angiogenesis, and the PI3K/Akt signaling pathway.

methodsWe used the NOX2 inhibitor apocynin to study the role of NOX2 in brain injury and functional recovery in a middle cerebral artery occlusion (MCAO) stroke mouse model. Infarct size, neurological deficits and behavior were evaluated on days 3, 7, 10 and 14 after reperfusion. In addition, dynamic NOX2-induced ROS levels were measured by dihydroethidium (DHE) staining. Autophagy, inflammasomes, and angiogenesis were measured by immunofluorescence staining and western blotting. RNA sequencing was performed, and bioinformatics technology was used to analyze differentially expressed genes (DEGs), as well as the enrichment of biological functions and signaling pathways in ischemia penumbra at 7 days after reperfusion. Then, Akt pathway-related proteins were further evaluated by western blotting.

resultsOur results showed that apocynin injection attenuated infarct size and mortality 3 days after stroke but promoted mortality and blocked functional recovery from 5 to 14 days after stroke. DHE staining showed that ROS levels were increased at 3 days after reperfusion and then gradually declined in WT mice, and these levels were significantly reduced by the NOX2 inhibitor apocynin. RNA-Seq analysis indicated that apocynin activated the immune response under hypoxic conditions. The immunofluorescence and western blot results demonstrated that apocynin inhibited the NLRP3 inflammasome and promoted angiogenesis at 3 days but promoted the NLRP3 inflammasome and inhibited angiogenesis at 7 and 14 days after stroke, which was mediated by regulating autophagy activation. Furthermore, RNA-Seq and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis indicated that apocynin injection resulted in PI3K-Akt signaling pathway enrichment after 7 days of MCAO. We then used an animal model to show that apocynin decreased the protein levels of phosphorylated PI3K and Akt and NF-κB p65, confirming that the PI3K-Akt-NF-κB pathway is involved in apocynin-mediated activation of inflammation and inhibition of angiogenesis.

conclusionsNOX2-induced ROS production is a double-edged sword that exacerbates brain injury in the acute phase but promotes functional recovery. This effect appears to be achieved by inhibiting NLRP3 inflammasome activation and promoting angiogenesis via autophagy activation.

Indexed as

Brain InjuriesBrain IschemiaReperfusion InjuryStrokeAnimalsDisease Models, AnimalInfarction, Middle Cerebral ArteryInflammasomesMiceNADPH Oxidase 2NF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen SpeciesInflammasomesNADPH Oxidase 2NF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen SpeciesAngiogenesisAutophagyIschemic strokeNADPHNLRP3 inflammasomeROS

Identifiers

PMID35836200
PMCPMC9281066
OpenAlexW4285386107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.